Autolus Therapeutics

NASDAQ: AUTL · Real-Time Price · USD
1.73
-0.12 (-6.49%)
At close: Aug 15, 2025, 3:59 PM
1.76
1.73%
After-hours: Aug 15, 2025, 07:55 PM EDT

Autolus Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-220.66M -208.38M -148.84M -142.1M
Depreciation & Amortization
7.72M 6.57M 7.42M 8.46M
Stock-Based Compensation
15.47M 11.2M 12.01M 9.94M
Other Working Capital
n/a 801K 3.95M 5.95M
Other Non-Cash Items
15.04M 45.72M 13.39M 1.77M
Deferred Income Tax
-185K -986K -268K -72K
Change in Working Capital
-23.66M 292K 3.97M 4.14M
Operating Cash Flow
-206.27M -145.59M -112.31M -117.86M
Capital Expenditures
-34.82M -10.99M -10.84M -8.86M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-12.74M n/a n/a n/a
Investing Cash Flow
-394.55M -10.99M -10.84M -8.86M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a -883K 59.76M 38.16M
Financial Cash Flow
589.55M -883K 223.61M 284.06M
Net Cash Flow
-11.53M -142.43M 72.08M 156.59M
Free Cash Flow
-241.09M -156.57M -123.15M -126.72M